SRPT Snapshot
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapies, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. The company is headquartered in Cambridge, Massachusetts.
VALUATION DATA
Market Capitalization$12,150,521,000
Price to Sales4.00
Earnings per Share$-5.7900
PE RatioNone
PRICE DATA
Most Recent Close$129.4600
52 Week High$9.77
52 Week Low$14.22
50-Day Moving Average$9.6
200-Day Moving Average$-26.32
All data are from Alpha Vantage as of today. For more infomation on SRPT see Stock Dividend, Valuation, Price and Financial Data for Investors